查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239437

骨科植入物市場：按產品類型、生物材料、類型劃分：2022-2032 年，全球機遇分析和行業預測

Orthopedic Implants Market By Product Type, By Biomaterial, By Type : Global Opportunity Analysis and Industry Forecast, 2022-2032
出版日期: | 出版商: Allied Market Research | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

全球骨科植入物市場預計在 2022 年為 471.9057 億美元，2023 年至 2032 年的複合年增長率為 4.5%，到 2032 年將達到 733.2675 億美元。增長。

骨科植入物是一種醫療設備，用於替換或支撐體內受損或缺失的骨骼。 骨科植入物分為兩組：永久植入物和臨時植入物。 永久性骨科植入物用於臀部、膝蓋、腳踝、肩膀、肘部、手腕和指關節，並且在人的一生中都存在於人體中。

臨時植入物還包括板、螺釘、銷釘、金屬絲和髓內釘，它們會在骨骼癒合時短時間存在。 骨科植入物用於治療多種疾病，包括骨關節炎、骨折和脊柱疾病。 骨科植入物包括關節置換術，例如髖關節和膝關節置換術、脊柱固定裝置以及用於固定骨折的板和螺釘。 它們由金屬、塑料、陶瓷和各種聚合物等材料製成。

推動骨科植入物市場增長的主要因素是骨關節炎和其他退行性疾病患病率上升、技術進步使植入物更有效、更持久，以及人口老齡化加劇。 此外，運動相關傷害的增加預計將推動市場增長。

例如，美國國家安全委員會2022年發布的一份報告指出，與2020年相比，2021年運動和休閒傷害將增加20%。運動相關傷害的上升預計將推動市場生長。 此外，人口老齡化更容易患上和診斷出關節炎、脫臼和骨折等骨科疾病，因此預計老年人口的增加將推動市場增長。

例如，根據美國老年醫學會發表的 2021 年論文，美國有 6000 萬人超過 65 歲，其中 80% 患有肌肉骨骼疾病。不斷增長的老年人口將推動骨科植入物市場的增長。 此外，骨科植入物的技術創新、骨科植入物的日益普及以及新興國家醫療保健基礎設施的改善都進一步推動了骨科植入物市場的增長。

但是，與涉及骨科植入物治療的程序相關的高成本是阻礙骨科植入物市場增長的一個因素。 此外，政府對植入物及其治療的嚴格政策預計也將抑制市場增長。 此外，對骨科植入物和技術進步的需求不斷增加，這些因素為骨科植入物市場的主要參與者提供了有利可圖的機會。 全球骨科植入物市場分為產品、類型、生物材料和地區。 按產品劃分，公司分為重建關節、脊柱植入物、牙科植入物、創傷、生物製品和其他。 重建關節置換部分分為四肢，包括膝關節置換、髖關節置換、上肢重建和下肢重建。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資領域
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭激烈
  • 市場動態
    • 司機
      • 骨科疾病患病率上升
      • 骨科植入物領域的技術進步
      • 對骨科植入物的需求激增
    • 約束因素
      • 骨科植入物的高成本
      • 植入手術的並發症
    • 機會
      • 新興市場的增長機會
  • 分析 COVID-19 對市場的影響

第 4 章骨科植入物市場：按產品類型分類

  • 概覽
    • 市場規模和預測
  • 重建性關節置換手術
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 重建關節置換骨科植入物市場，按類型
      • 肢體骨科植入物市場，按類型
      • 上肢重建骨科植入物市場，按類型
      • 下肢重建骨科植入物市場，按類型
  • 脊柱植入物
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 脊柱植入物 骨科植入物市場，按類型
      • 脊柱固定植入物 骨科植入物市場，按類型
      • 脊椎壓縮性骨折 (VCF) 裝置骨科植入物市場，按類型
      • 運動保留裝置/非融合裝置骨科植入物市場，按類型
  • 種植牙
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 牙科植入物和骨科植入物市場，按類型
  • 創傷
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 正畸生物學
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 骨科骨科植入物市場，按類型
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章骨科植入物市場：按生物材料分類

  • 概覽
    • 市場規模和預測
  • 金屬生物材料
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
    • 金屬生物材料骨科植入物市場，按類型
  • 陶瓷生物材料
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 高分子生物材料
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章骨科植入物市場：按類型分類

  • 概覽
    • 市場規模和預測
  • 膝蓋
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 臀部
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 手腕和肩膀
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 牙科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 書脊
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 腳踝
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章骨科植入物市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 按產品類型劃分的市場規模和預測
    • 市場規模和預測：按生物材料分類
    • 市場規模和按類型預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
  • 歐洲
    • 主要趨勢和機會
    • 按產品類型劃分的市場規模和預測
    • 市場規模和預測：按生物材料分類
    • 市場規模和按類型預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
  • 亞太地區
    • 主要趨勢和機會
    • 按產品類型劃分的市場規模和預測
    • 市場規模和預測：按生物材料分類
    • 市場規模和按類型預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 按產品類型劃分的市場規模和預測
    • 市場規模和預測：按生物材料分類
    • 市場規模和按類型預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測
      • 拉丁美洲其他地區/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 按產品類型劃分的市場規模和預測
      • 市場規模和預測：按生物材料分類
      • 市場規模和按類型預測

第八章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2022 年

第九章公司簡介

  • Arthrex, Inc.
  • Colfax Corporation（DJO GLOBAL LLC）
  • CONMED Corporation
  • Globus Medical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • NuVasive Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: A01845

The global orthopedic implants market was valued at $47,190.57 million in 2022 and is estimated to reach $73,326.75 million by 2032, exhibiting a CAGR of 4.5% from 2023 to 2032.

Orthopedic implants are medical devices used to replace or support the damaged or missing bones in the body. Orthopedic implants are divided into two groups such as permanent implants and temporary implants. Permanent orthopedic implants are used for hip, knee, ankle, shoulder, elbow, wrist, and finger joints, which are present in the human body throughout the life span of an individual.

Further, temporary orthopedic implants include plates, screws, pins, wires, and intramedullary nails, which are present for shorter periods just long enough to let the bones heal. Orthopedic implants are used to treat a variety of conditions such as osteoarthritis, fractures, and spinal disorders. Orthopedic implants include joint replacements (such as hip and knee replacement), spinal fusion devices, plates and screws used to stabilize fractures. They are made of materials such as metals, plastics, ceramic, and various polymers.

The major factors driving the growth of the orthopedic implants market are increase in incidences of osteoarthritis and other degenerative diseases, technological advancements that allow more effective and long-lasting implants and rise in geriatric population. In addition, a rise in the number of sports-related injuries is also expected to drive the growth of the market.

For instance, according to report published by the National Safety Council of the U.S. 2022 stated that in 2021, 20% rise in sports and recreational injuries was observed as compared to 2020, thus a rise in number of sport related injuries is expected to drive the growth of the market. Further, geriatric population is prone to develop and diagnose orthopedicdiseases such as arthritis, dislocation of bones and fractures, thus rise in geriatric population is anticipated to drive the growth of the market.

For instance, according to an article published by American Geriatric Society 2021 stated that 60 million people in the U.S. are aged 65 years or above and 80% of these population suffer from musculoskeletal conditions, thus rise in geriatric population drives the growth of orthopedic implant market. In addition, the rise in technological innovations in orthopedic implants, rise in adoption of orthopedic implants and improvement of healthcare infrastructure in the emerging countries, further supplement the growth of orthopedic implant market.

However, the high cost associated with procedures involving orthopedic implants treatment is the factor which hampers the growth of orthopedic implants market. In addition, stringent government policies regarding implants and their procedures are also expected to restrain the growth of the market. Furthermore, the rise in demand for orthopedic implants and rise in technological advancements are the factors which offer lucrative opportunities to the key players of orthopedic implants market. The global orthopedic implants market is segmented into product, type, biomaterial, and region. On the basis of product, the market is categorized into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. The reconstructive joint replacements segment is segmented into knee replacement implants, hip replacement implants, and extremities that include upper extremity reconstruction and lower extremity reconstruction.

In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implants are again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others.

On the basis of type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. On the basis of biomaterial, the market is categorized into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global orthopedic implants market are: Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic implants market analysis from 2022 to 2032 to identify the prevailing orthopedic implants market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the orthopedic implants market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global orthopedic implants market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Reconstructive Joint Replacements
    • Type
    • Knee Replacement Implants
    • Hip Replacement Implants
    • Extremities
  • Type
  • Spinal Implants
    • Type
    • Spinal fusion implants
  • Type
    • Invasive Spinal bone stimulators
    • Vertebral Compression Fracture (VCF) Devices
  • Type
    • Motion Preservation Devices/Non-Fusion Devices
  • Type
  • Dental Implants
    • Type
    • Root Form Dental Implants
    • Plate Form Dental Implants
  • Trauma
  • Orthobiologics
    • Type
    • Demineralized Bone Matrix (DBM)
    • Allograft
    • Bone Morphogenetic Protein (BMP)
    • Viscosupplementation Products
    • Synthetic Bone Substitutes
    • Others
  • Others

By Biomaterial

  • Metallic Biomaterials
    • Type
    • Stainless steel
    • Titanium Alloy
    • Cobalt Alloy
    • Others
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Others

By Type

  • Wrist and Shoulder
  • Dental
  • Spine
  • Ankle
  • Others
  • Knee
  • Hip

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Zimmer Biomet Holdings Inc.
  • Arthrex, Inc.
  • Globus Medical, Inc.
  • Medtronic plc
  • Smith & Nephew plc
  • NuVasive Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • Stryker Corporation
  • Colfax Corporation (DJO GLOBAL LLC)

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. High bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. High intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of orthopedic disorders
      • 3.4.1.2. Technological advancements in the field of orthopedic implants
      • 3.4.1.3. Surge in demand of orthopedic implants
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of orthopedic implant
      • 3.4.2.2. Complications with implant procedure
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reconstructive Joint Replacements
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Reconstructive Joint Replacements Orthopedic Implants Market by Type
      • 4.2.4.1. Extremities Orthopedic Implants Market by Type
      • 4.2.4.1.1. Upper Extremity Reconstruction Orthopedic Implants Market by Type
      • 4.2.4.1.1. Lower Extremity Reconstruction Orthopedic Implants Market by Type
  • 4.3. Spinal Implants
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Spinal Implants Orthopedic Implants Market by Type
      • 4.3.4.1. Spinal fusion implants Orthopedic Implants Market by Type
      • 4.3.4.2. Vertebral Compression Fracture (VCF) Devices Orthopedic Implants Market by Type
      • 4.3.4.3. Motion Preservation Devices/Non-Fusion Devices Orthopedic Implants Market by Type
  • 4.4. Dental Implants
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Dental Implants Orthopedic Implants Market by Type
  • 4.5. Trauma
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Orthobiologics
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country
    • 4.6.4. Orthobiologics Orthopedic Implants Market by Type
  • 4.7. Others
    • 4.7.1. Key market trends, growth factors and opportunities
    • 4.7.2. Market size and forecast, by region
    • 4.7.3. Market share analysis by country

CHAPTER 5: ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Metallic Biomaterials
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Metallic Biomaterials Orthopedic Implants Market by Type
  • 5.3. Ceramic Biomaterials
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Polymeric Biomaterials
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ORTHOPEDIC IMPLANTS MARKET, BY TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Knee
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hip
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Wrist and Shoulder
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Dental
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Spine
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country
  • 6.7. Ankle
    • 6.7.1. Key market trends, growth factors and opportunities
    • 6.7.2. Market size and forecast, by region
    • 6.7.3. Market share analysis by country
  • 6.8. Others
    • 6.8.1. Key market trends, growth factors and opportunities
    • 6.8.2. Market size and forecast, by region
    • 6.8.3. Market share analysis by country

CHAPTER 7: ORTHOPEDIC IMPLANTS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product Type
    • 7.2.3. Market size and forecast, by Biomaterial
    • 7.2.4. Market size and forecast, by Type
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product Type
      • 7.2.5.1.3. Market size and forecast, by Biomaterial
      • 7.2.5.1.4. Market size and forecast, by Type
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product Type
      • 7.2.5.2.3. Market size and forecast, by Biomaterial
      • 7.2.5.2.4. Market size and forecast, by Type
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product Type
      • 7.2.5.3.3. Market size and forecast, by Biomaterial
      • 7.2.5.3.4. Market size and forecast, by Type
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product Type
    • 7.3.3. Market size and forecast, by Biomaterial
    • 7.3.4. Market size and forecast, by Type
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product Type
      • 7.3.5.1.3. Market size and forecast, by Biomaterial
      • 7.3.5.1.4. Market size and forecast, by Type
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product Type
      • 7.3.5.2.3. Market size and forecast, by Biomaterial
      • 7.3.5.2.4. Market size and forecast, by Type
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product Type
      • 7.3.5.3.3. Market size and forecast, by Biomaterial
      • 7.3.5.3.4. Market size and forecast, by Type
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product Type
      • 7.3.5.4.3. Market size and forecast, by Biomaterial
      • 7.3.5.4.4. Market size and forecast, by Type
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product Type
      • 7.3.5.5.3. Market size and forecast, by Biomaterial
      • 7.3.5.5.4. Market size and forecast, by Type
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product Type
      • 7.3.5.6.3. Market size and forecast, by Biomaterial
      • 7.3.5.6.4. Market size and forecast, by Type
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product Type
    • 7.4.3. Market size and forecast, by Biomaterial
    • 7.4.4. Market size and forecast, by Type
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product Type
      • 7.4.5.1.3. Market size and forecast, by Biomaterial
      • 7.4.5.1.4. Market size and forecast, by Type
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product Type
      • 7.4.5.2.3. Market size and forecast, by Biomaterial
      • 7.4.5.2.4. Market size and forecast, by Type
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product Type
      • 7.4.5.3.3. Market size and forecast, by Biomaterial
      • 7.4.5.3.4. Market size and forecast, by Type
      • 7.4.5.4. India
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product Type
      • 7.4.5.4.3. Market size and forecast, by Biomaterial
      • 7.4.5.4.4. Market size and forecast, by Type
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product Type
      • 7.4.5.5.3. Market size and forecast, by Biomaterial
      • 7.4.5.5.4. Market size and forecast, by Type
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product Type
      • 7.4.5.6.3. Market size and forecast, by Biomaterial
      • 7.4.5.6.4. Market size and forecast, by Type
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product Type
    • 7.5.3. Market size and forecast, by Biomaterial
    • 7.5.4. Market size and forecast, by Type
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product Type
      • 7.5.5.1.3. Market size and forecast, by Biomaterial
      • 7.5.5.1.4. Market size and forecast, by Type
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product Type
      • 7.5.5.2.3. Market size and forecast, by Biomaterial
      • 7.5.5.2.4. Market size and forecast, by Type
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product Type
      • 7.5.5.3.3. Market size and forecast, by Biomaterial
      • 7.5.5.3.4. Market size and forecast, by Type
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product Type
      • 7.5.5.4.3. Market size and forecast, by Biomaterial
      • 7.5.5.4.4. Market size and forecast, by Type

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Arthrex, Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Key strategic moves and developments
  • 9.2. Colfax Corporation (DJO GLOBAL LLC)
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. CONMED Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Globus Medical, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Johnson & Johnson
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Medtronic plc
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. NuVasive Inc.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Smith & Nephew plc
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Stryker Corporation
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Zimmer Biomet Holdings Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 02. ORTHOPEDIC IMPLANTS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 03. GLOBAL RECONSTRUCTIVE JOINT REPLACEMENTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL EXTREMITIES ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 05. GLOBAL UPPER EXTREMITY RECONSTRUCTION ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 06. GLOBAL LOWER EXTREMITY RECONSTRUCTION ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 07. ORTHOPEDIC IMPLANTS MARKET FOR SPINAL IMPLANTS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL SPINAL IMPLANTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 09. GLOBAL SPINAL FUSION IMPLANTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 10. GLOBAL VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 11. GLOBAL MOTION PRESERVATION DEVICES/NON-FUSION DEVICES ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 12. ORTHOPEDIC IMPLANTS MARKET FOR DENTAL IMPLANTS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 13. GLOBAL DENTAL IMPLANTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 14. ORTHOPEDIC IMPLANTS MARKET FOR TRAUMA, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 15. ORTHOPEDIC IMPLANTS MARKET FOR ORTHOBIOLOGICS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 16. GLOBAL ORTHOBIOLOGICS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 17. ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 19. ORTHOPEDIC IMPLANTS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 20. GLOBAL METALLIC BIOMATERIALS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 21. ORTHOPEDIC IMPLANTS MARKET FOR CERAMIC BIOMATERIALS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 22. ORTHOPEDIC IMPLANTS MARKET FOR POLYMERIC BIOMATERIALS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 23. ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 25. ORTHOPEDIC IMPLANTS MARKET FOR KNEE, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 26. ORTHOPEDIC IMPLANTS MARKET FOR HIP, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 27. ORTHOPEDIC IMPLANTS MARKET FOR WRIST AND SHOULDER, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 28. ORTHOPEDIC IMPLANTS MARKET FOR DENTAL, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 29. ORTHOPEDIC IMPLANTS MARKET FOR SPINE, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 30. ORTHOPEDIC IMPLANTS MARKET FOR ANKLE, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 31. ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 32. ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022-2032 (REVENUE, $MILLION)
  • TABLE 33. NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 34. NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 35. NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 36. NORTH AMERICA ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 (REVENUE, $MILLION)
  • TABLE 37. U.S. ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 38. U.S. ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 39. U.S. ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 40. CANADA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 41. CANADA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 42. CANADA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 43. MEXICO ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 44. MEXICO ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 45. MEXICO ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 46. EUROPE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 47. EUROPE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 48. EUROPE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 49. EUROPE ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 (REVENUE, $MILLION)
  • TABLE 50. GERMANY ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 51. GERMANY ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 52. GERMANY ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 53. FRANCE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 54. FRANCE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 55. FRANCE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 56. UK ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 57. UK ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 58. UK ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 59. ITALY ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 60. ITALY ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 61. ITALY ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 62. SPAIN ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 63. SPAIN ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 64. SPAIN ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 65. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 66. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 67. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 68. ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 69. ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 70. ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 71. ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 (REVENUE, $MILLION)
  • TABLE 72. JAPAN ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 73. JAPAN ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 74. JAPAN ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 75. CHINA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 76. CHINA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 77. CHINA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 78. AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 79. AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 80. AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 81. INDIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 82. INDIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 83. INDIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 84. SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 85. SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 86. SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 87. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 88. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 89. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 90. LAMEA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 91. LAMEA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 92. LAMEA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 93. LAMEA ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 (REVENUE, $MILLION)
  • TABLE 94. BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 95. BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 96. BRAZIL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 97. SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 98. SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 99. SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 100. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 101. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 102. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 103. REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 104. REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022-2032 (REVENUE, $MILLION)
  • TABLE 105. REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022-2032 (REVENUE, $MILLION)
  • TABLE 106. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 107. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 108. ARTHREX, INC.: PRODUCT SEGMENTS
  • TABLE 109. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 110. ARTHREX, INC.: KEY STRATERGIES
  • TABLE 111. COLFAX CORPORATION (DJO GLOBAL LLC): KEY EXECUTIVES
  • TABLE 112. COLFAX CORPORATION (DJO GLOBAL LLC): COMPANY SNAPSHOT
  • TABLE 113. COLFAX CORPORATION (DJO GLOBAL LLC): PRODUCT SEGMENTS
  • TABLE 114. COLFAX CORPORATION (DJO GLOBAL LLC): PRODUCT PORTFOLIO
  • TABLE 115. COLFAX CORPORATION (DJO GLOBAL LLC): KEY STRATERGIES
  • TABLE 116. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 117. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 118. CONMED CORPORATION: PRODUCT SEGMENTS
  • TABLE 119. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. CONMED CORPORATION: KEY STRATERGIES
  • TABLE 121. GLOBUS MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 122. GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 123. GLOBUS MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 124. GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 125. GLOBUS MEDICAL, INC.: KEY STRATERGIES
  • TABLE 126. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 127. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 128. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 129. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 130. JOHNSON & JOHNSON: KEY STRATERGIES
  • TABLE 131. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 132. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 133. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 134. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 135. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 136. NUVASIVE INC.: KEY EXECUTIVES
  • TABLE 137. NUVASIVE INC.: COMPANY SNAPSHOT
  • TABLE 138. NUVASIVE INC.: PRODUCT SEGMENTS
  • TABLE 139. NUVASIVE INC.: PRODUCT PORTFOLIO
  • TABLE 140. NUVASIVE INC.: KEY STRATERGIES
  • TABLE 141. SMITH & NEPHEW PLC: KEY EXECUTIVES
  • TABLE 142. SMITH & NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 143. SMITH & NEPHEW PLC: PRODUCT SEGMENTS
  • TABLE 144. SMITH & NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 145. SMITH & NEPHEW PLC: KEY STRATERGIES
  • TABLE 146. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 147. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 148. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 149. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 150. STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 151. ZIMMER BIOMET HOLDINGS INC.: KEY EXECUTIVES
  • TABLE 152. ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT
  • TABLE 153. ZIMMER BIOMET HOLDINGS INC.: PRODUCT SEGMENTS
  • TABLE 154. ZIMMER BIOMET HOLDINGS INC.: PRODUCT PORTFOLIO
  • TABLE 155. ZIMMER BIOMET HOLDINGS INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ORTHOPEDIC IMPLANTS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ORTHOPEDIC IMPLANTS MARKET, 2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN ORTHOPEDIC IMPLANTS MARKET (2023-2032)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. HIGH INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALORTHOPEDIC IMPLANTS MARKET
  • FIGURE 10. ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR RECONSTRUCTIVE JOINT REPLACEMENTS, BY COUNTRY 2022-2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR SPINAL IMPLANTS, BY COUNTRY 2022-2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR DENTAL IMPLANTS, BY COUNTRY 2022-2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR TRAUMA, BY COUNTRY 2022-2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR ORTHOBIOLOGICS, BY COUNTRY 2022-2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 17. ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2022(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY 2022-2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR CERAMIC BIOMATERIALS, BY COUNTRY 2022-2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR POLYMERIC BIOMATERIALS, BY COUNTRY 2022-2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 22. ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR KNEE, BY COUNTRY 2022-2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR HIP, BY COUNTRY 2022-2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR WRIST AND SHOULDER, BY COUNTRY 2022-2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR DENTAL, BY COUNTRY 2022-2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR SPINE, BY COUNTRY 2022-2032(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR ANKLE, BY COUNTRY 2022-2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022-2032(%)
  • FIGURE 30. ORTHOPEDIC IMPLANTS MARKET BY REGION, 2022
  • FIGURE 31. U.S. ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. CANADA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. MEXICO ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. GERMANY ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. FRANCE ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. UK ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. ITALY ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SPAIN ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. JAPAN ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. CHINA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. AUSTRALIA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. INDIA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH KOREA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. BRAZIL ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. SAUDI ARABIA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. REST OF LAMEA ORTHOPEDIC IMPLANTS MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: ORTHOPEDIC IMPLANTS MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2022
  • FIGURE 57. COLFAX CORPORATION (DJO GLOBAL LLC): NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. COLFAX CORPORATION (DJO GLOBAL LLC): REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. COLFAX CORPORATION (DJO GLOBAL LLC): REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. CONMED CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CONMED CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CONMED CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. GLOBUS MEDICAL, INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 64. GLOBUS MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 65. GLOBUS MEDICAL, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 66. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 67. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 69. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 72. NUVASIVE INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 73. NUVASIVE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74. NUVASIVE INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 75. SMITH & NEPHEW PLC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 76. SMITH & NEPHEW PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 77. SMITH & NEPHEW PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 78. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 79. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 80. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 81. ZIMMER BIOMET HOLDINGS INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 82. ZIMMER BIOMET HOLDINGS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 83. ZIMMER BIOMET HOLDINGS INC.: REVENUE SHARE BY REGION, 2021 (%)